Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
FHTX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $124.12M
- EPS (TTM)
- -$0.98
- Dividend yield
- None
- 52-week range
- 1.79 – 7.61
- Day range
- 1.91 – 2.15
- Volume / Avg
- 913.13K / 617.56K
- Beta
- —
- Shares outstanding
- 59.39M
- Next earnings
- Nov 4, 2026
52-week range
FHTX stock today
Foghorn Therapeutics (FHTX) closed at $2.09 on Oct 7, up 6.09% (+$0.12), versus the S&P 500's 0.22% decline. At this level, FHTX sits near the bottom of its 52-week range of $1.79 to $7.61: 72.5% below the high, set on Aug 20, 2026 and 16.8% above the low. FHTX is down 61.3% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 52.7%.
Foghorn Therapeutics has posted a net loss over the last twelve months (EPS of -$0.98), so its P/E ratio is not meaningful. Foghorn Therapeutics's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Foghorn Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2020
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-0.23
Foghorn Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| COYACoya Therapeutics Inc. | 4.91 | +1.24% | $115.18M | vs FHTX |
| INOInovio Pharmaceuticals Inc. | 1.16 | +2.21% | $119.42M | vs FHTX |
| UNCYUnicycive Therapeutics Inc. | 4.18 | -1.18% | $114.50M | vs FHTX |
| RANIRani Therapeutics Holdings Inc. Class A | 0.8121 | -2.02% | $114.12M | vs FHTX |
| GNLXGenelux Corporation | 2.52 | -0.79% | $114.02M | vs FHTX |
| QUCYQuantum Cyber N.V. | 1.43 | +10.85% | $120.22M | vs FHTX |
| PMVPPMV Pharmaceuticals Inc. | 1.50 | -6.83% | $113.27M | vs FHTX |
| VTVTvTv Therapeutics Inc. Class A | 31.01 | +3.26% | $122.61M | vs FHTX |
Indexes, lists and sector
Foghorn Therapeutics stock FAQ
What is Foghorn Therapeutics's stock price today?
FHTX last traded at $2.09 as of Oct 7, 4:00 PM EDT, up 6.09% on the day. Prices are delayed at least 15 minutes.
When is Foghorn Therapeutics's next earnings date?
Foghorn Therapeutics is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-0.23.
What is the FHTX 52-week high?
The 52-week high for FHTX is $7.61 and the 52-week low is $1.79. The stock is currently 72.5% below its high.